Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year

Core Insights - Intelligent Bio Solutions Inc. achieved a record revenue of over $1 million for the fiscal first quarter ended September 30, 2025, marking a significant milestone for the company [2] - The company reported a revenue increase of approximately 32% sequentially and 28% year-over-year, indicating strong growth momentum [2][3] - Cartridge revenue rose approximately 43% year-over-year, while reader revenue increased by about 23% year-over-year, reflecting the effectiveness of the company's business model [2] Revenue Performance - The company has experienced three consecutive quarters of revenue growth, showcasing the strength of its razor-razorblade business model [2] - The anticipated revenue growth is attributed to an improved sales mix, with higher-margin consumables making up a larger share of total revenue [2] Company Overview - Intelligent Bio Solutions Inc. specializes in intelligent, rapid, non-invasive testing solutions, particularly through its Intelligent Fingerprinting Drug Screening System [4] - The technology is designed for quick sample collection and results, making it suitable for safety-critical industries such as construction, manufacturing, and transport [4]